//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Every discovery starts with reading 📚 From papers to datasets to code, our library helps turn knowledge into impact – powering open access and scientific discovery. Read more 👉 https://sangerinstitute.blog/2026/06/11/how-our-library-powers-discovery-and-open-access/
Sloths are the slowest mammals on the planet and now we know why. Scientists have sequenced the two-toed sloth genome and found ‘jumping genes’ linked to their extremely slow metabolism 🦥 Read more here ⤵️ https://www.sanger.ac.uk/news_item/why-are-sloths-so-slow-its-in-their-dna/
The largest cellular study of gut tissue reveals how differences in DNA influence the genes and pathways driving inflammatory bowel disease, pointing to new therapeutic targets. 🧬 Read the story below: 👇 https://bit.ly/3Qk4tAP
Find out more about BASE Rx and Matt Coelho’s journey to co-founding the spin-out in our latest blog 👉 https://sangerinstitute.blog/2026/05/26/from-bases-to-breakthroughs-editing-cancers-weak-spots-with-crispr/
3h
1d
7d
16d
sangerinstitute.blog
How our library powers discovery and open access - Wellcome Sanger Institute Blog
Largest cellular study of gut tissue unveils the genes and pathways driving inflammatory bowel disease, suggesting new therapeutic targets.
www.sanger.ac.uk
In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founde...
sangerinstitute.blog
Study of millions of cells reveals new way to understand genetic risk of disease
From bases to breakthroughs: Editing cancer’s weak spots with CRISPR - Wellcome Sanger Institute Blog
The programme will support BASE Rx as it develops faster, more effective approaches to cancer treatment, providing mentoring, workshops and investor support to help accelerate the company’s growth. 📈
We are launching a new AI consortium for genomics, in partnership with Google DeepMind and with support from Google.org. 🧬 The consortium will build large-scale, AI-ready genomic datasets to power breakthrough discoveries and advance biological research. Read here 👇 bit.ly/3RTG6dK
The largest study of its kind focused on the healthy human gut microbiome is underway in Bangladesh. 🧬 Our latest blog follows Archana Madhav and her large-scale effort to study the human gut through stool samples. 💩 https://sangerinstitute.blog/2026/06/04/chasing-the-secrets-of-healthy-stool/
Read 'Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease risk' by @opentargets.org @sangerinstitute.bsky.social and @cuh.nhs.uk in @nature.com ⬇️ https://www.nature.com/articles/s41586-026-10627-z
Read ‘Elevated retrocopy burden and sloth-specific expansions illuminate mammalian genome evolution’ from the Sanger Institute, Leibniz Institute for Zoo and Wildlife Research (IZW), Hospital Sírio Libanês and others in @bmc.springernature.com, here: link.springer.com/article/10.1...